Amyloid PET disclosure in subjective cognitive decline: Patient experiences over timeHeleen M.A. Hendriksen, Wiesje M. van der Flier, Tanja J. de Rijke et al.|Alzheimer s & Dementia|2024Cited by 15
Amyloid‐PET disclosure in Subjective Cognitive Decline: patient experiences and outcomes over timeHeleen M.A. Hendriksen, Wiesje M. van der Flier, Tanja J. de Rijke et al.|Alzheimer s & Dementia|2024Cited by 1
Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive declineJetske van der Schaar, Eva C. A. Asscher, Wiesje M. van der Flier et al.|Alzheimer s Research & Therapy|2026Cited by 0
Additional file 2 of Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive declineJetske van der Schaar, Eva C. A. Asscher, Wiesje M. van der Flier et al.|Figshare|2026Cited by 0
Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive declineJetske van der Schaar, Eva C. A. Asscher, Wiesje M. van der Flier et al.|Figshare|2026Cited by 0